Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Weve known for years that NAD+ therapy, administered via injection or IV, is an excellent way to replenish depleted NAD+
AOD 9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (GH fragment 176191), structurally modified with an N-terminal tyrosine residue to enhance stability in experimental systems
Observed outcomes are dependent on experimental context, concentration, and model design, making AOD9604 a useful tool for mechanistic studies examining domain-specific activity of growth hormonederived peptides
Sleep quality, stress management, and hormonal health also impact metabolic responsiveness to the peptide
AOD 9604/MOTS-c is given as a subcutaneous injection on a provider-determined schedule
Center, S
US$ 22.89
US$ 26.37
US$ 25.05
US$ 22.49
